Watershed Asset Management L.L.C. Acquires New Stake in Humana Inc. $HUM

Watershed Asset Management L.L.C. acquired a new stake in shares of Humana Inc. (NYSE:HUM) in the 1st quarter, HoldingsChannel reports. The institutional investor acquired 2,735 shares of the insurance provider’s stock, valued at approximately $474,000.

A number of other large investors have also bought and sold shares of HUM. Capital International Investors lifted its position in shares of Humana by 113.9% during the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after buying an additional 3,097,571 shares during the last quarter. Norges Bank purchased a new stake in Humana in the 4th quarter worth about $456,632,000. Pzena Investment Management LLC raised its stake in Humana by 34.3% in the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock valued at $948,614,000 after acquiring an additional 1,398,774 shares during the period. Wellington Management Group LLP raised its stake in Humana by 4,481.7% in the 4th quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider’s stock valued at $306,460,000 after acquiring an additional 1,170,387 shares during the period. Finally, Franklin Resources Inc. lifted its holdings in Humana by 914.5% during the fourth quarter. Franklin Resources Inc. now owns 1,255,665 shares of the insurance provider’s stock valued at $321,613,000 after purchasing an additional 1,131,893 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently weighed in on HUM. TD Cowen lifted their target price on shares of Humana from $211.00 to $350.00 and gave the stock a “hold” rating in a research note on Tuesday. Leerink Partners upped their price target on shares of Humana from $185.00 to $255.00 and gave the company a “market perform” rating in a research note on Thursday, April 30th. Deutsche Bank Aktiengesellschaft downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday, May 20th. Needham & Company LLC started coverage on shares of Humana in a report on Wednesday, May 20th. They set a “buy” rating on the stock. Finally, JPMorgan Chase & Co. increased their target price on Humana from $214.00 to $316.00 and gave the stock a “neutral” rating in a research report on Monday, June 8th. Two investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, fifteen have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Humana has an average rating of “Hold” and a consensus price target of $325.87.

Humana Trading Up 3.6%

Shares of HUM opened at $400.51 on Friday. The business’s 50-day moving average price is $354.03 and its 200-day moving average price is $260.19. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $428.88. The stock has a market cap of $48.09 billion, a PE ratio of 42.84, a P/E/G ratio of 2.09 and a beta of 0.71. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. Humana’s revenue was up 23.5% compared to the same quarter last year. During the same period last year, the business earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities analysts forecast that Humana Inc. will post 9.53 EPS for the current fiscal year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.